title: First the ESBLs, now the Carbapenemases: Where will it End?
authors.forename: Rajeev
authors.initials: R
authors.lastname: Soman
authors.forename: Anjali
authors.initials: A
authors.lastname: Shetty
authors.forename: Camilla
authors.initials: C
authors.lastname: Rodrigues
mesh_terms: D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology*; D015780:Carbapenems; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans; D008297:Male; D018440:beta-Lactam Resistance
chemical_list: D015780:Carbapenems